Literature DB >> 23545783

Molecularly imprinted polymers prepared using protein-conjugated cleavable monomers followed by site-specific post-imprinting introduction of fluorescent reporter molecules.

Yusuke Suga1, Hirobumi Sunayama, Tooru Ooya, Toshifumi Takeuchi.   

Abstract

Molecularly imprinted polymers were prepared using a protein-conjugated disulfide cleavable monomer. After removing the protein by disulfide reduction, a thiol-reactive fluorophore was introduced into the thiol residue located only inside the imprinted cavity, resulting in specific transduction of the binding events into fluorescence spectral change.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23545783     DOI: 10.1039/c3cc40484f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

1.  Block copolymer synthesis using free-radical polymerization and thiol-maleimide 'click' conjugation.

Authors:  Talena Rambarran; Heather D Sheardown
Journal:  RSC Adv       Date:  2021-10-26       Impact factor: 4.036

2.  Oriented, molecularly imprinted cavities with dual binding sites for highly sensitive and selective recognition of cortisol.

Authors:  Narito Suda; Hirobumi Sunayama; Yukiya Kitayama; Yuri Kamon; Toshifumi Takeuchi
Journal:  R Soc Open Sci       Date:  2017-08-16       Impact factor: 2.963

3.  Isothiocyanate-Functionalized Mesoporous Silica Nanoparticles as Building Blocks for the Design of Nanovehicles with Optimized Drug Release Profile.

Authors:  Gabriel Martínez-Edo; Maria C Llinàs; Salvador Borrós; David Sánchez-García
Journal:  Nanomaterials (Basel)       Date:  2019-08-29       Impact factor: 5.076

4.  A simple approach to prepare fluorescent molecularly imprinted nanoparticles.

Authors:  Fenying Wang; Dan Wang; Tingting Wang; Yu Jin; Baoping Ling; Qianjin Li; Jianlin Li
Journal:  RSC Adv       Date:  2021-02-17       Impact factor: 3.361

5.  Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.

Authors:  Sarah M Ward; Matthew Skinner; Banishree Saha; Todd Emrick
Journal:  Mol Pharm       Date:  2018-10-15       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.